Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Zejula 100mg Tablets

Active Ingredient:
niraparib tosylate monohydrate
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
L01XK02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Dear HCP Letter for Zejula (niraparib) 100mg film-coated tablets

GlaxoSmithKline (GSK) is repacking specific batches of ZEJULA (niraparib) 100mg film-coated tablets to ensure patient access to the latest Patient Information Leaflet (PIL).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]